Skip to content

BPro BT Ambulatory Blood Pressure Monitoring System with BProSoft BT PC Software

by Healthstats International Pte Ltd

510(k) K173028

Active European Union and United States

CE MDR 510(k)

Valid until

Not listed

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Special NumberK173028 Date21 Jun 2018ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA Product Code
DXN
FDA applicant
Healthstats International Pte. , Ltd.
Device Class
Class II
Regulation
21 CFR Part 870.1130
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The BPro BT Ambulatory Blood Pressure Monitoring System with BProSoft BT PC Software is a noninvasive ambulatory blood pressure monitoring device classified under product code DXN. It employs arterial tonometry at the radial artery of the wrist to measure blood pressure continuously over extended periods, providing detailed cardiovascular monitoring for clinical assessment.

This system comprises a wrist-mounted BPro BT tonometric monitor, a BPCalibrator MC3100+ oscillometric device for calibration, and BProSoft BT PC software for data analysis. Supplied as a reusable medical device, it is intended for use in clinical settings and has received FDA 510(k) clearance under Special Review, along with MDR authorization. The device requires proper storage and calibration to ensure accurate readings.

Other devices from Healthstats International Pte Ltd

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the BPro BT Ambulatory Blood Pressure Monitoring System, and how does it differ from traditional blood pressure cuffs?

    The BPro BT system is designed for continuous, noninvasive ambulatory blood pressure monitoring by measuring arterial tonometry at the radial artery on the wrist. Unlike traditional cuff-based devices that take intermittent readings, this system provides detailed cardiovascular assessment over extended periods, making it ideal for tracking blood pressure trends outside of a clinical setting. It combines a wrist-mounted monitor with a calibration device (BPCalibrator MC3100+) and software for data analysis, ensuring accuracy through periodic oscillometric validation.

  • Is the BPro BT device single-use or reusable, and what maintenance does it require?

    The BPro BT system is reusable and intended for clinical use, meaning it can be used across multiple patients with proper cleaning and maintenance. To ensure accurate readings, it requires regular calibration using the included BPCalibrator MC3100+ device. Additionally, storage conditions must be followed to preserve functionality, as the manufacturer emphasizes proper handling to maintain performance.

  • How does the BProSoft BT PC software factor into the device’s functionality, and what role does it play in clinical use?

    The BProSoft BT PC software is a critical component of the system, as it analyzes and visualizes the continuous blood pressure data collected by the wrist-mounted monitor. Clinicians use it to interpret trends, generate reports, and assess cardiovascular health over time. The software integrates with the calibration device to validate measurements, ensuring the data remains reliable for clinical assessment.

  • What regulatory pathways has the BPro BT system undergone, and what does that mean for its clinical adoption?

    The BPro BT system has received FDA 510(k) clearance under Special Review and MDR authorization, confirming its compliance with regulatory standards for ambulatory blood pressure monitoring. This means it has been evaluated for safety and effectiveness by the FDA and meets EU medical device regulations, providing confidence in its clinical adoption for noninvasive cardiovascular monitoring in healthcare settings.